Selling shares in a private company is fundamentally different from trading stock on a public exchange. The process is governed by contractual agreements, corporate bylaws, and securities regulations that prioritize the control and stability of the business over the liquidity of the shareholder. Worth adding: there is no centralized marketplace, no real-time ticker tape, and no guaranteed pool of buyers. Whether you are an early employee exercising options, a founder seeking partial liquidity, or an angel investor rotating capital, understanding the mechanics, restrictions, and strategic nuances is essential to executing a successful transaction The details matter here..
Understanding the Landscape of Private Equity
Before initiating a sale, the shareholder must grasp the structural reality of private company stock. Worth adding: ), recent funding rounds, or negotiated agreements between parties. Because of that, s. On top of that, the company itself usually retains significant control over who can become a shareholder. Unlike public shares, these securities are illiquid assets. On the flip side, their value is not determined by daily market forces but by periodic valuations (409A valuations in the U. This control is exercised through legal mechanisms embedded in the shareholders' agreement, the articles of incorporation, and the bylaws.
The first step in any sale is a thorough review of these governing documents. You are not simply selling an asset; you are navigating a web of contractual rights and obligations designed to protect the company and existing stakeholders.
Key Contractual Restrictions: The Gatekeepers
Most private companies implement specific restrictions to manage their capitalization table (cap table). Ignoring these can render a transfer void or trigger legal disputes. The three most common restrictions are:
1. Right of First Refusal (ROFR) This is the standard gatekeeping mechanism. Before you can sell your shares to an outside third party, you must offer them to the company (and sometimes to existing investors) on the exact same terms—price, quantity, and conditions. The company typically has a defined window (often 30 to 60 days) to decide whether to purchase the shares. If they decline or do not act within the window, you are generally free to proceed with the third-party buyer, provided other conditions are met.
2. Co-Sale Rights (Tag-Along Rights) Often held by major investors (Series A, B, etc.), this provision allows them to participate in any sale you negotiate with a third party. If you find a buyer for 10,000 shares, an investor with co-sale rights can insist on selling a proportional amount of their own shares to that same buyer at the same price. This dilutes the number of shares you can actually offload in a single transaction.
3. Transfer Restrictions and Board Approval Even if ROFR is waived or expires, the bylaws frequently require Board of Directors consent for any transfer. The board has a fiduciary duty to assess whether the new shareholder aligns with the company’s long-term interests. They may reject a transfer to a competitor, a hostile party, or simply someone they deem unsuitable. Some agreements also impose "lock-up" periods following funding rounds or IPO filings, during which no transfers are permitted whatsoever.
Valuation: Determining What Your Shares Are Worth
Without a public market price, valuation becomes a negotiation. There are three primary benchmarks used in private transactions:
- The 409A Valuation (Fair Market Value): In the U.S., companies are required to obtain an independent appraisal (usually annually or after material events) to set the strike price for employee stock options. This is often the floor for common stock pricing, though it typically applies a discount for lack of marketability (DLOM) and lack of control.
- Preferred Price (Last Round Valuation): Investors buy preferred stock, which carries liquidation preferences, anti-dilution protection, and voting rights. Common stock (held by founders and employees) is subordinate. So, common stock usually trades at a discount to the preferred price—often 10% to 30% lower, depending on the company’s stage and proximity to an exit.
- Secondary Market Comps: Platforms like Forge, EquityZen, or Hiive enable secondary transactions. Reviewing recent trades of your specific company’s stock on these platforms provides the most realistic "market" data point, though access to this data is often gated.
The Step-by-Step Sale Process
Once you have confirmed your right to sell and established a target price range, the transaction follows a defined workflow.
1. Secure Company Cooperation
You cannot close a private sale unilaterally. You need the company’s legal counsel to draft or approve the Stock Purchase Agreement (SPA), update the cap table, and issue new stock certificates (or update the electronic ledger). Initiate a conversation with the CFO, General Counsel, or a designated "equity administrator" early. Some companies are cooperative; others actively discourage secondary sales to keep the cap table clean.
2. Identify a Buyer
Finding a buyer is often the hardest part. Potential sources include:
- Existing Investors: They know the company, have pro-rata rights, and may want to increase ownership.
- Current Employees/Executives: High-net-worth individuals within the organization often seek more equity.
- Secondary Market Platforms: Broker-dealers specializing in private securities (e.g., Forge Global, EquityZen, Nasdaq Private Market). They match sellers with accredited investors but charge fees (typically 3–5% per side) and require company cooperation.
- Direct Outreach: Family offices, venture capital secondaries funds, or high-net-worth individuals. This requires significant networking and legal compliance (Reg D, Rule 144 considerations).
3. Negotiate Terms and Execute the SPA
The Stock Purchase Agreement is the core legal document. It covers:
- Purchase Price: Per share and aggregate.
- Representations and Warranties: You must represent that you own the shares free and clear of liens, that you are an accredited investor (usually), and that you are not in possession of material non-public information (MNPI)—though sellers often do have MNPI, requiring careful legal navigation (Section 10b-5 compliance).
- Indemnification: Protection for the buyer if your representations prove false.
- Closing Conditions: Explicitly listing ROFR waiver, Board consent, and regulatory clearances.
4. handle the ROFR Process
Formally notify the company of the bona fide offer. The company exercises or waives its right. If they exercise, they become the buyer at your negotiated terms. If they waive, you proceed to the third party. Major investors then exercise or waive their co-sale rights The details matter here. Which is the point..
5. Obtain Board Consent
Submit the executed SPA and buyer information (KYC/AML checks, investor questionnaire) to the Board. This is a formal agenda item. Rejection is rare if the buyer passes compliance checks, but it is a legal requirement.
6. Closing and Settlement
Funds are transferred (often via escrow for larger deals), the SPA is countersigned by the company, the stock ledger is updated, and new certificates are issued. The buyer is now a shareholder of record Still holds up..
Alternative Paths: Tender Offers and Company-Sponsored Liquidity
Increasingly, late-stage private companies (Unicorns) run structured tender offers (or "liquidity events") once a year or every 18 months. In this scenario, the company itself (or a designated buyer group) offers to buy shares from employees and early investors at a set price during a specific window.
Short version: it depends. Long version — keep reading The details matter here..
- Pros: Guaranteed liquidity, no need to find a buyer, company handles legal/admin, price is set (no negotiation stress).
- Cons: You cannot choose the
You cannot choose the buyer or the exact timing of the sale; the company sets both the price and the window, which may leave you with less favorable terms than a negotiated secondary‑market transaction. Beyond that, participation is often capped—only a certain percentage of outstanding shares may be tendered—so larger holders may need to supplement the offer with a private sale to achieve their desired liquidity level.
Other Viable Routes to Liquidity
| Option | Typical Participants | Key Advantages | Main Drawbacks |
|---|---|---|---|
| Company‑initiated buyback | The issuer itself (often using cash reserves) | Simplifies paperwork; price is usually at or near the last round valuation; no third‑party negotiation required | Reduces the company’s cash balance; may be limited by board approval or debt covenants |
| Secondary‑market fund | Dedicated secondaries funds, family offices, or high‑net‑worth individuals | Access to sophisticated buyers who understand private‑company nuances; can structure earn‑outs or contingent payments | Funds often seek a discount (10‑30 %) to compensate for illiquidity and execution risk |
| Employee stock purchase plan (ESPP) or RSU liquidity program | Current employees (and sometimes former employees) | Aligns with retention goals; can be run internally with minimal external legal overhead | Usually restricted to employees; pricing may be tied to a formula that lags market value |
| Strategic investor or corporate partner | Corporations looking for a stake or technology access | May pay a premium for strategic synergies; can open doors to future partnerships or M&A | Requires alignment of interests; due diligence can be lengthy; may trigger change‑of‑control provisions |
| Public‑market pathways (IPO, direct listing, SPAC) | Public investors | Provides the most transparent price discovery and highest potential upside | Involves significant regulatory, accounting, and underwriting costs; lock‑up periods delay immediate cash; market volatility can affect proceeds |
Choosing the Right Path
- Clarify your liquidity objective – Are you looking for a quick cash infusion, a partial exit while retaining upside, or a full divestiture?
- Assess the company’s stance – Some founders are open to secondary sales; others impose strict ROFR or consent thresholds that can make private negotiations cumbersome.
- Evaluate buyer quality and price certainty – Tender offers give price certainty but limited buyer choice; direct negotiations can yield higher proceeds if you find a strategic buyer willing to pay a premium.
- Factor in timing and costs – Escrow fees, legal expenses, and potential tax implications (e.g., qualifying for long‑term capital gains vs. ordinary income) vary widely across mechanisms.
- Run a sensitivity analysis – Model net proceeds under each scenario, incorporating likely discounts, fees, and tax rates, to see which route meets your financial target with the least friction.
Practical Tips for a Smooth Transaction
- Prepare a clean cap table – Ensure all option exercises, vesting schedules, and prior transfers are up‑to‑date; discrepancies delay board consent and trigger indemnity claims.
- Gather accreditation documentation early – Most private‑market buyers require proof of accredited investor status; having letters from your CPA or a third‑party verifier speeds up KYC/AML checks.
- Use escrow for larger deals – A neutral third party holds funds until all closing conditions (ROFR waiver, board consent, stock ledger update) are satisfied, protecting both sides.
- Mind the lock‑up and leave‑behind provisions – If you remain an employee or consultant after the sale, check whether any post‑termination obligations (e.g., non‑compete, invention assignment) could affect your ability to retain or later sell the shares.
- Document everything – Minutes of board consent, signed waivers, and the final SPA should be stored securely; they become critical if any dispute arises over ownership or indemnity.
Conclusion
Selling shares in a private company is no longer a one‑size‑fits‑all endeavor. While traditional routes—finding a buyer, navigating ROFR, securing board consent, and closing via an SPA—remain the backbone of secondary transactions, the rise of company‑sponsored tender offers, structured buybacks, and specialized secondaries funds has expanded the toolkit available to shareholders. By carefully weighing liquidity goals, the company’s policies, buyer characteristics
By carefully weighing liquidity goals, the company’s policies, buyer characteristics and broader market conditions, shareholders can handle the complexities of secondary sales with confidence. A well‑structured approach—whether through a tender offer, a negotiated secondary, or a structured buyback—ensures that the transaction aligns with both immediate cash needs and long‑term wealth objectives The details matter here..
At the end of the day, the most successful exits are those that combine meticulous preparation, transparent communication with the company’s governance bodies, and a clear understanding of the financial implications. By leveraging professional advisors, conducting rigorous sensitivity modeling, and documenting every step, sellers protect themselves from unexpected delays, disputes, or tax inefficiencies And that's really what it comes down to..
In today’s dynamic private‑market landscape, the ability to choose the right liquidity pathway is a strategic advantage. Think about it: shareholders who master this art not only access value on their terms but also position themselves for future opportunities, whether that means reinvesting in the business, diversifying their portfolio, or simply achieving the financial freedom they set out to obtain. The journey may be layered, but with the right framework in place, the destination is well within reach.
